OTHER
DOCUMENTS

Present treatments, such as Propranolol, are capable of reducing tremor amplitude by up to 50% but exhibit efficacy in only approximately 40% of patients. Additionally, some potentially effective pharmacological agents have been associated with intolerable adverse effects. There is a critical need to enhance outcome measures through the establishment of standardized methods for assessing tremor severity, thereby facilitating the evaluation of treatment efficacy.